Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,700 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients.
Park B, Sohn JY, Yoon KA, Lee KS, Cho EH, Lim MC, Yang MJ, Park SJ, Lee MH, Lee SY, Chang YJ, Lee DO, Kong SY, Lee ES. Park B, et al. Among authors: lee sy, lee ks, lee mh, lee do, lee es. Breast Cancer Res Treat. 2017 May;163(1):139-150. doi: 10.1007/s10549-017-4142-7. Epub 2017 Feb 15. Breast Cancer Res Treat. 2017. PMID: 28205045 Free PMC article.
The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study.
Yoon YS, Lee ES, Park C, Lee S, Oh SW. Yoon YS, et al. Among authors: lee es, lee s. Int J Obes (Lond). 2007 Mar;31(3):528-34. doi: 10.1038/sj.ijo.0803442. Epub 2006 Jul 25. Int J Obes (Lond). 2007. PMID: 16865099
Epidermal growth factor receptor status in anaplastic thyroid carcinoma.
Lee DH, Lee GK, Kong SY, Kook MC, Yang SK, Park SY, Park SH, Keam B, Park DJ, Cho BY, Kim SW, Chung KW, Lee ES, Kim SW. Lee DH, et al. Among authors: lee gk, lee es. J Clin Pathol. 2007 Aug;60(8):881-4. doi: 10.1136/jcp.2006.041251. Epub 2006 Nov 1. J Clin Pathol. 2007. PMID: 17079354 Free PMC article.
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer.
Lee KS, Ro J, Nam BH, Lee ES, Kwon Y, Kwon HS, Chung KW, Kang HS, Kim EA, Kim SW, Shin KH, Kim SK. Lee KS, et al. Among authors: lee es. Breast Cancer Res Treat. 2008 Jun;109(3):481-9. doi: 10.1007/s10549-007-9672-y. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653851 Clinical Trial.
2,700 results